A new anti-HER2 IgE antibody potentially offers new therapy options for treatment-resistant breast and ovarian cancers.
The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback